Remove Aortic Remove Bicuspid/Mitral Remove Tricuspid
article thumbnail

Smidt Heart Institute Physicians Advance Transcatheter Tricuspid Valve Replacement

DAIC

Physicians in the Smidt Heart Institute at Cedars-Sinai have pioneered using a catheter-based approach to treat patients with tricuspid valve disease. The first 100 minimally invasive tricuspid procedures were done as part of the TRISCEND II clinical trial. Image by Getty. Image by Getty. Food and Drug Administration (FDA).

Tricuspid 105
article thumbnail

Outcomes Following Transcatheter Aortic Valve Replacement for Aortic Stenosis in Patients With Type 0 Bicuspid, Type 1 Bicuspid, and Tricuspid Aortic Valves

Circulation: Cardiovascular Interventions

BACKGROUND:Data concerning the outcomes of transcatheter aortic valve replacement in type 0 bicuspid aortic stenosis (AS) are scarce. Ascending aortic diameter was the single predictor of 1-year mortality in type 0 bicuspid patients (hazard ratio, 1.59 [95% CI, 1.03–2.44];P=0.035). Poverall=0.765; 1 year: 1.4%

article thumbnail

The Society of Thoracic Surgeons Launches New Valve Surgery Risk Calculators

DAIC

Tricuspid Valve Repair Existing literature on national surgical outcomes of isolated tricuspid valve repair or replacement is based on data from over a decade ago and may not reflect current practice results. Analysis of 13,587 patients undergoing isolated tricuspid valve surgery from 2017 to 2023 revealed a 5.5%

TAVR 111
article thumbnail

Mild Tricuspid Regurgitation

All About Cardiovascular System and Disorders

Transcipt of video: Mild tricuspid regurgitation is often noted on echocadiogram reports and sometimes causes a little bit of worry and a lot of questions are asked on mild tricuspid regurgitation. What is this mild tricuspid regurgitation? And mild tricuspid regurgitation is just a small leak from the tricuspid valve.

article thumbnail

Predictors of post-TAVI conduction abnormalities in patients with bicuspid aortic valves

Open Heart

Objectives This study evaluates predictors of conduction abnormalities (CA) following transcatheter aortic valve implantation (TAVI) in patients with bicuspid aortic valves (BAV). Predictors of CA are well established among patients with tricuspid aortic valves but not in those with BAV. to 41.00; p=0.01.

article thumbnail

Edwards Lifesciences to Sell Critical Care to BD

DAIC

The sale enhances Edwards’ balance sheet flexibility for disciplined investments in technologies for aortic, mitral, tricuspid and pulmonic patients, as well as new therapeutic areas for interventional heart failure.

article thumbnail

Transcatheter versus surgical valve replacement in patients with bicuspid aortic valves: an updated meta-analysis

The British Journal of Cardiology

Patients with bicuspid aortic valves (BAV) are predisposed to the development of aortic stenosis. We performed a pairwise meta-analysis, comparing the efficacy of transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) in patients with BAV. to 4.58, p=0.04).